Skip to Content

Ziconotide Pregnancy and Breastfeeding Warnings

Ziconotide is also known as: Prialt

Medically reviewed on December 15, 2017.

Ziconotide Pregnancy Warnings

Ziconotide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality as evidenced by significant increases in post-implantation loss. Animal maternal toxicity has been reported to have lead to reduced fetal weighs and transient, delayed ossification of the pubic bones. There are no controlled data in human pregnancy. Ziconotide should only be given during pregnancy when benefits outweigh risks.

See references

Ziconotide Breastfeeding Warnings

There are no data on the excretion of ziconotide into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to ziconotide in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Prialt (ziconotide)." Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.

References for breastfeeding information

  1. "Product Information. Prialt (ziconotide)." Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide